Rank | Gene Set | Z-score |
---|---|---|
1 | doxorubicin metabolic process (GO:0044598) | 9.95518140 |
2 | daunorubicin metabolic process (GO:0044597) | 9.95518140 |
3 | polyketide metabolic process (GO:0030638) | 9.95518140 |
4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 8.90194580 |
5 | * cellular glucuronidation (GO:0052695) | 8.15311779 |
6 | * glucuronate metabolic process (GO:0019585) | 7.64614235 |
7 | * uronic acid metabolic process (GO:0006063) | 7.64614235 |
8 | exogenous drug catabolic process (GO:0042738) | 7.41922671 |
9 | negative regulation of fibrinolysis (GO:0051918) | 7.04716128 |
10 | drug catabolic process (GO:0042737) | 6.77069724 |
11 | regulation of fibrinolysis (GO:0051917) | 6.68135512 |
12 | epoxygenase P450 pathway (GO:0019373) | 6.68086585 |
13 | L-phenylalanine catabolic process (GO:0006559) | 6.64450092 |
14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.64450092 |
15 | L-phenylalanine metabolic process (GO:0006558) | 6.54056472 |
16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.54056472 |
17 | regulation of protein activation cascade (GO:2000257) | 6.39994093 |
18 | urea metabolic process (GO:0019627) | 6.34360558 |
19 | complement activation, alternative pathway (GO:0006957) | 6.19445612 |
20 | omega-hydroxylase P450 pathway (GO:0097267) | 6.10978724 |
21 | glyoxylate metabolic process (GO:0046487) | 6.04464167 |
22 | regulation of complement activation (GO:0030449) | 5.95429791 |
23 | flavonoid metabolic process (GO:0009812) | 5.90391190 |
24 | nitrogen cycle metabolic process (GO:0071941) | 5.71556890 |
25 | fibrinolysis (GO:0042730) | 5.67387243 |
26 | primary alcohol catabolic process (GO:0034310) | 5.44225177 |
27 | urea cycle (GO:0000050) | 5.41627926 |
28 | drug metabolic process (GO:0017144) | 5.25437730 |
29 | phenylpropanoid metabolic process (GO:0009698) | 5.05463892 |
30 | glycoside metabolic process (GO:0016137) | 5.00526209 |
31 | bile acid and bile salt transport (GO:0015721) | 4.93296067 |
32 | bile acid metabolic process (GO:0008206) | 4.90915731 |
33 | protein carboxylation (GO:0018214) | 4.83621080 |
34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.83621080 |
35 | intestinal cholesterol absorption (GO:0030299) | 4.81183439 |
36 | ethanol oxidation (GO:0006069) | 4.80272788 |
37 | bile acid biosynthetic process (GO:0006699) | 4.72560938 |
38 | negative regulation of cholesterol transport (GO:0032375) | 4.67603394 |
39 | negative regulation of sterol transport (GO:0032372) | 4.67603394 |
40 | aromatic amino acid family catabolic process (GO:0009074) | 4.60442412 |
41 | drug transmembrane transport (GO:0006855) | 4.58561783 |
42 | blood coagulation, intrinsic pathway (GO:0007597) | 4.53050686 |
43 | amino-acid betaine metabolic process (GO:0006577) | 4.42249535 |
44 | retinal metabolic process (GO:0042574) | 4.29209878 |
45 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.28019588 |
46 | hormone catabolic process (GO:0042447) | 4.27215871 |
47 | negative regulation of hemostasis (GO:1900047) | 4.26192317 |
48 | negative regulation of blood coagulation (GO:0030195) | 4.26192317 |
49 | xenobiotic catabolic process (GO:0042178) | 4.15471771 |
50 | serine family amino acid catabolic process (GO:0009071) | 4.12249137 |
51 | regulation of plasminogen activation (GO:0010755) | 4.07104217 |
52 | negative regulation of lipase activity (GO:0060192) | 4.06651257 |
53 | oxidative demethylation (GO:0070989) | 4.04884056 |
54 | glycine metabolic process (GO:0006544) | 4.01932926 |
55 | ethanol metabolic process (GO:0006067) | 4.00501694 |
56 | negative regulation of coagulation (GO:0050819) | 3.92694657 |
57 | protein activation cascade (GO:0072376) | 3.91984228 |
58 | quinone metabolic process (GO:1901661) | 3.90900587 |
59 | negative regulation of wound healing (GO:0061045) | 3.90027493 |
60 | progesterone metabolic process (GO:0042448) | 3.85901524 |
61 | drug transport (GO:0015893) | 3.82598083 |
62 | phospholipid efflux (GO:0033700) | 3.77313412 |
63 | negative regulation of protein activation cascade (GO:2000258) | 3.75543567 |
64 | cysteine metabolic process (GO:0006534) | 3.69814409 |
65 | complement activation, classical pathway (GO:0006958) | 3.66398944 |
66 | acute-phase response (GO:0006953) | 3.66138197 |
67 | regulation of humoral immune response (GO:0002920) | 3.64912157 |
68 | complement activation (GO:0006956) | 3.62692425 |
69 | response to mercury ion (GO:0046689) | 3.62465194 |
70 | S-adenosylmethionine metabolic process (GO:0046500) | 3.61119985 |
71 | positive regulation of hemostasis (GO:1900048) | 3.57513691 |
72 | positive regulation of blood coagulation (GO:0030194) | 3.57513691 |
73 | regulation of triglyceride catabolic process (GO:0010896) | 3.54376770 |
74 | heme transport (GO:0015886) | 3.53097160 |
75 | acylglycerol homeostasis (GO:0055090) | 3.50963801 |
76 | triglyceride homeostasis (GO:0070328) | 3.50963801 |
77 | phosphate ion transmembrane transport (GO:0035435) | 3.49879054 |
78 | serine family amino acid metabolic process (GO:0009069) | 3.49440505 |
79 | * xenobiotic metabolic process (GO:0006805) | 3.47574218 |
80 | tyrosine metabolic process (GO:0006570) | 3.45717969 |
81 | coenzyme catabolic process (GO:0009109) | 3.44011578 |
82 | cellular aldehyde metabolic process (GO:0006081) | 3.42641723 |
83 | arginine metabolic process (GO:0006525) | 3.40897429 |
84 | C21-steroid hormone metabolic process (GO:0008207) | 3.34920109 |
85 | retinoic acid metabolic process (GO:0042573) | 3.34202726 |
86 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.33979539 |
87 | regulation of cholesterol esterification (GO:0010872) | 3.33478464 |
88 | positive regulation of coagulation (GO:0050820) | 3.32257977 |
89 | citrulline biosynthetic process (GO:0019240) | 3.31803907 |
90 | cofactor catabolic process (GO:0051187) | 3.29060120 |
91 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.26844079 |
92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.25476060 |
93 | primary alcohol metabolic process (GO:0034308) | 3.25015350 |
94 | glutamate metabolic process (GO:0006536) | 3.22552672 |
95 | response to nitrosative stress (GO:0051409) | 3.21890829 |
96 | urate metabolic process (GO:0046415) | 3.18784840 |
97 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.13761950 |
98 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.13412233 |
99 | regulation of apoptotic cell clearance (GO:2000425) | 3.13380943 |
100 | high-density lipoprotein particle remodeling (GO:0034375) | 3.12574548 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.40747745 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.48745898 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.74653701 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.60261185 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.39650059 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.37206950 |
7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.91671697 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.77269891 |
9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.64876090 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.53648360 |
11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.18198807 |
12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.84615542 |
13 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.60234290 |
14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.48881643 |
15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.36799474 |
16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.26660825 |
17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.23228225 |
18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.21000770 |
19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.09946033 |
20 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.04374732 |
21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.97561945 |
22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.96981648 |
23 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.88597367 |
24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.85581797 |
25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.85129250 |
26 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.84389916 |
27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.78893781 |
28 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.77364155 |
29 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.75849486 |
30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72120626 |
31 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.69197900 |
32 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.66471672 |
33 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58033172 |
34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.57929074 |
35 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.50416082 |
36 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.47812426 |
37 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.47275403 |
38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46522303 |
39 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46250514 |
40 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.44378927 |
41 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.44378927 |
42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39829397 |
43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39633503 |
44 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38630807 |
45 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.33117292 |
46 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.28505299 |
47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.28155589 |
48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26206308 |
49 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22605820 |
50 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.22523098 |
51 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19011327 |
52 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.17092982 |
53 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16290090 |
54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13353855 |
55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09459577 |
56 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09370333 |
57 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08208169 |
58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06726316 |
59 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02533718 |
60 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02302926 |
61 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01878807 |
62 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99890187 |
63 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96930877 |
64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96634520 |
65 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.95149896 |
66 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90739026 |
67 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90493475 |
68 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.89895606 |
69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89181936 |
70 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88505614 |
71 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88397532 |
72 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.82397085 |
73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79148814 |
74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.78842153 |
75 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.78110178 |
76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77120585 |
77 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.75255754 |
78 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74137929 |
79 | CJUN_26792858_Chip-Seq_BT549_Human | 0.73714431 |
80 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.73280493 |
81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71804146 |
82 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.70765722 |
83 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.70324755 |
84 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.69707001 |
85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.68996008 |
86 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.68942061 |
87 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.68527782 |
88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.68127277 |
89 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.67441851 |
90 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.64119482 |
91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.64048144 |
92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.63172458 |
93 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.63040515 |
94 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.61726369 |
95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.61617499 |
96 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.60898271 |
97 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.59017120 |
98 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.58597541 |
99 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58281313 |
100 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.57960625 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.87114647 |
2 | MP0005365_abnormal_bile_salt | 5.65459511 |
3 | MP0008875_abnormal_xenobiotic_pharmacok | 5.61819698 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.49019719 |
5 | MP0005360_urolithiasis | 5.21586274 |
6 | MP0002138_abnormal_hepatobiliary_system | 4.39345379 |
7 | MP0003252_abnormal_bile_duct | 4.21104123 |
8 | MP0003195_calcinosis | 3.26810104 |
9 | MP0003868_abnormal_feces_composition | 3.17760460 |
10 | MP0001666_abnormal_nutrient_absorption | 3.08483281 |
11 | MP0003806_abnormal_nucleotide_metabolis | 2.74196613 |
12 | MP0005332_abnormal_amino_acid | 2.43984219 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.18042608 |
14 | MP0009840_abnormal_foam_cell | 2.16523034 |
15 | MP0010329_abnormal_lipoprotein_level | 2.15205781 |
16 | MP0009697_abnormal_copulation | 2.00870044 |
17 | MP0009053_abnormal_anal_canal | 1.90965663 |
18 | MP0000609_abnormal_liver_physiology | 1.71558655 |
19 | MP0004019_abnormal_vitamin_homeostasis | 1.71530462 |
20 | MP0010234_abnormal_vibrissa_follicle | 1.64076749 |
21 | MP0005451_abnormal_body_composition | 1.60439493 |
22 | MP0003705_abnormal_hypodermis_morpholog | 1.44190053 |
23 | MP0002118_abnormal_lipid_homeostasis | 1.43880887 |
24 | MP0005408_hypopigmentation | 1.40104866 |
25 | MP0009643_abnormal_urine_homeostasis | 1.33496529 |
26 | MP0005023_abnormal_wound_healing | 1.27571136 |
27 | MP0005319_abnormal_enzyme/_coenzyme | 1.20862627 |
28 | MP0001661_extended_life_span | 1.20068377 |
29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14094215 |
30 | MP0010386_abnormal_urinary_bladder | 1.10950538 |
31 | MP0003186_abnormal_redox_activity | 1.10192233 |
32 | MP0002796_impaired_skin_barrier | 1.10012602 |
33 | MP0002876_abnormal_thyroid_physiology | 1.06538431 |
34 | MP0001764_abnormal_homeostasis | 1.05177528 |
35 | MP0000467_abnormal_esophagus_morphology | 1.04993010 |
36 | MP0003566_abnormal_cell_adhesion | 1.02419080 |
37 | MP0003656_abnormal_erythrocyte_physiolo | 0.96368986 |
38 | MP0003453_abnormal_keratinocyte_physiol | 0.95822383 |
39 | MP0003879_abnormal_hair_cell | 0.94438024 |
40 | MP0010368_abnormal_lymphatic_system | 0.91226458 |
41 | MP0000598_abnormal_liver_morphology | 0.90878907 |
42 | MP0001756_abnormal_urination | 0.90226864 |
43 | MP0003638_abnormal_response/metabolism_ | 0.89792229 |
44 | MP0005058_abnormal_lysosome_morphology | 0.89451659 |
45 | MP0004782_abnormal_surfactant_physiolog | 0.87756463 |
46 | MP0001348_abnormal_lacrimal_gland | 0.86081975 |
47 | MP0000566_synostosis | 0.85414587 |
48 | MP0005670_abnormal_white_adipose | 0.76599014 |
49 | MP0004272_abnormal_basement_membrane | 0.74792340 |
50 | MP0009642_abnormal_blood_homeostasis | 0.74588117 |
51 | MP0002136_abnormal_kidney_physiology | 0.72088524 |
52 | MP0002098_abnormal_vibrissa_morphology | 0.71790662 |
53 | MP0005501_abnormal_skin_physiology | 0.71190127 |
54 | MP0001915_intracranial_hemorrhage | 0.70861411 |
55 | MP0001851_eye_inflammation | 0.70169845 |
56 | MP0005376_homeostasis/metabolism_phenot | 0.69322527 |
57 | MP0010678_abnormal_skin_adnexa | 0.69066010 |
58 | MP0004264_abnormal_extraembryonic_tissu | 0.68908157 |
59 | MP0005636_abnormal_mineral_homeostasis | 0.68906718 |
60 | MP0002249_abnormal_larynx_morphology | 0.68412470 |
61 | MP0008469_abnormal_protein_level | 0.66728236 |
62 | MP0003941_abnormal_skin_development | 0.64515693 |
63 | MP0005164_abnormal_response_to | 0.62251969 |
64 | MP0009763_increased_sensitivity_to | 0.61108021 |
65 | MP0002060_abnormal_skin_morphology | 0.59434581 |
66 | MP0003690_abnormal_glial_cell | 0.59423754 |
67 | MP0002909_abnormal_adrenal_gland | 0.59138055 |
68 | MP0005187_abnormal_penis_morphology | 0.58540161 |
69 | MP0003878_abnormal_ear_physiology | 0.57460493 |
70 | MP0005377_hearing/vestibular/ear_phenot | 0.57460493 |
71 | MP0000003_abnormal_adipose_tissue | 0.57024536 |
72 | MP0000604_amyloidosis | 0.56469772 |
73 | MP0005076_abnormal_cell_differentiation | 0.56422378 |
74 | MP0005464_abnormal_platelet_physiology | 0.56310764 |
75 | MP0005395_other_phenotype | 0.56148911 |
76 | MP0002168_other_aberrant_phenotype | 0.55569698 |
77 | MP0000858_altered_metastatic_potential | 0.55046162 |
78 | MP0001216_abnormal_epidermal_layer | 0.54765255 |
79 | MP0000579_abnormal_nail_morphology | 0.54203024 |
80 | MP0002971_abnormal_brown_adipose | 0.53785312 |
81 | MP0005197_abnormal_uvea_morphology | 0.53263778 |
82 | MP0002132_abnormal_respiratory_system | 0.52150506 |
83 | MP0003011_delayed_dark_adaptation | 0.51955101 |
84 | MP0000627_abnormal_mammary_gland | 0.51663399 |
85 | MP0000516_abnormal_urinary_system | 0.50941575 |
86 | MP0005367_renal/urinary_system_phenotyp | 0.50941575 |
87 | MP0009780_abnormal_chondrocyte_physiolo | 0.50724493 |
88 | MP0002928_abnormal_bile_duct | 0.49561210 |
89 | MP0008874_decreased_physiological_sensi | 0.47590978 |
90 | MP0003183_abnormal_peptide_metabolism | 0.47239540 |
91 | MP0000534_abnormal_ureter_morphology | 0.46700607 |
92 | MP0005248_abnormal_Harderian_gland | 0.45169941 |
93 | MP0005257_abnormal_intraocular_pressure | 0.44931940 |
94 | MP0001881_abnormal_mammary_gland | 0.43493078 |
95 | MP0005409_darkened_coat_color | 0.42958944 |
96 | MP0002697_abnormal_eye_size | 0.42819856 |
97 | MP0004233_abnormal_muscle_weight | 0.42763942 |
98 | MP0001849_ear_inflammation | 0.39612958 |
99 | MP0000249_abnormal_blood_vessel | 0.39525499 |
100 | MP0005083_abnormal_biliary_tract | 0.38811385 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.69822034 |
2 | Deep venous thrombosis (HP:0002625) | 8.20533469 |
3 | Complement deficiency (HP:0004431) | 7.64783226 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.02452575 |
5 | Hypobetalipoproteinemia (HP:0003563) | 6.94893842 |
6 | Conjugated hyperbilirubinemia (HP:0002908) | 6.93852806 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 6.69204661 |
8 | Abnormality of complement system (HP:0005339) | 6.48828433 |
9 | Abnormality of the common coagulation pathway (HP:0010990) | 5.41995279 |
10 | Intrahepatic cholestasis (HP:0001406) | 5.14531665 |
11 | Systemic lupus erythematosus (HP:0002725) | 5.11349894 |
12 | Glomerulonephritis (HP:0000099) | 5.06283725 |
13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.22376733 |
14 | Joint hemorrhage (HP:0005261) | 4.18467917 |
15 | Spontaneous abortion (HP:0005268) | 4.13738107 |
16 | Hypolipoproteinemia (HP:0010981) | 4.10358057 |
17 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.09692310 |
18 | Fat malabsorption (HP:0002630) | 4.08277256 |
19 | Nephritis (HP:0000123) | 4.02608151 |
20 | Xanthomatosis (HP:0000991) | 3.84519895 |
21 | Rickets (HP:0002748) | 3.58012221 |
22 | Vascular calcification (HP:0004934) | 3.45429922 |
23 | Steatorrhea (HP:0002570) | 3.42015739 |
24 | Hyperlipoproteinemia (HP:0010980) | 3.38811763 |
25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.30244845 |
26 | Mitral stenosis (HP:0001718) | 3.16574626 |
27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.13369045 |
28 | Hyperammonemia (HP:0001987) | 3.10286767 |
29 | Generalized aminoaciduria (HP:0002909) | 3.05812477 |
30 | Hypercholesterolemia (HP:0003124) | 3.04856050 |
31 | Cardiovascular calcification (HP:0011915) | 3.01659012 |
32 | Hemorrhage of the eye (HP:0011885) | 2.98554954 |
33 | Focal segmental glomerulosclerosis (HP:0000097) | 2.93291397 |
34 | Hyperbilirubinemia (HP:0002904) | 2.83296281 |
35 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.81393696 |
36 | Osteomalacia (HP:0002749) | 2.76079211 |
37 | Gingival bleeding (HP:0000225) | 2.75843650 |
38 | Abnormality of nucleobase metabolism (HP:0010932) | 2.69641552 |
39 | Abnormality of the Achilles tendon (HP:0005109) | 2.66091687 |
40 | Abnormality of methionine metabolism (HP:0010901) | 2.60609500 |
41 | Hepatocellular carcinoma (HP:0001402) | 2.58341787 |
42 | Glomerulosclerosis (HP:0000096) | 2.58004636 |
43 | Abnormality of proline metabolism (HP:0010907) | 2.39413593 |
44 | Hydroxyprolinuria (HP:0003080) | 2.39413593 |
45 | Gout (HP:0001997) | 2.37233172 |
46 | Abnormal gallbladder physiology (HP:0012438) | 2.36120014 |
47 | Cholecystitis (HP:0001082) | 2.36120014 |
48 | Hypoalphalipoproteinemia (HP:0003233) | 2.31564111 |
49 | Facial shape deformation (HP:0011334) | 2.27279338 |
50 | Potter facies (HP:0002009) | 2.27279338 |
51 | Purpura (HP:0000979) | 2.26432591 |
52 | Abnormality of vitamin metabolism (HP:0100508) | 2.25452895 |
53 | Increased serum ferritin (HP:0003281) | 2.24173280 |
54 | Hyperglycinuria (HP:0003108) | 2.23985240 |
55 | Cerebral palsy (HP:0100021) | 2.16136527 |
56 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.14815698 |
57 | Bifid scrotum (HP:0000048) | 2.13941775 |
58 | Cholelithiasis (HP:0001081) | 2.13660713 |
59 | Abnormality of glycine metabolism (HP:0010895) | 2.11361266 |
60 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.11361266 |
61 | Back pain (HP:0003418) | 2.11276586 |
62 | Elevated alkaline phosphatase (HP:0003155) | 2.10540882 |
63 | Hyperglycinemia (HP:0002154) | 2.10007708 |
64 | Reduced antithrombin III activity (HP:0001976) | 2.07617324 |
65 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.05667368 |
66 | Abnormality of purine metabolism (HP:0004352) | 2.05451622 |
67 | Menorrhagia (HP:0000132) | 2.04165633 |
68 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.02150828 |
69 | Joint swelling (HP:0001386) | 1.99208506 |
70 | Increased mean platelet volume (HP:0011877) | 1.99102755 |
71 | Reticulocytosis (HP:0001923) | 1.98237778 |
72 | Nuclear cataract (HP:0100018) | 1.96637265 |
73 | Abnormal gallbladder morphology (HP:0012437) | 1.96265856 |
74 | Abnormality of iron homeostasis (HP:0011031) | 1.95821876 |
75 | Thrombophlebitis (HP:0004418) | 1.92446307 |
76 | Hyperphosphaturia (HP:0003109) | 1.91957054 |
77 | Abnormality of urine glucose concentration (HP:0011016) | 1.91639151 |
78 | Glycosuria (HP:0003076) | 1.91639151 |
79 | Delayed CNS myelination (HP:0002188) | 1.91415659 |
80 | Abnormality of serum amino acid levels (HP:0003112) | 1.84708490 |
81 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.77899360 |
82 | Epidermoid cyst (HP:0200040) | 1.77862856 |
83 | Esophageal varix (HP:0002040) | 1.77201934 |
84 | Abnormal urine phosphate concentration (HP:0012599) | 1.74469507 |
85 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73740478 |
86 | Abdominal distention (HP:0003270) | 1.73463648 |
87 | Hypophosphatemic rickets (HP:0004912) | 1.73183375 |
88 | Metabolic acidosis (HP:0001942) | 1.70935626 |
89 | Abnormality of the gastric mucosa (HP:0004295) | 1.70106301 |
90 | Sex reversal (HP:0012245) | 1.69798355 |
91 | Abnormal sex determination (HP:0012244) | 1.69798355 |
92 | Abnormal platelet volume (HP:0011876) | 1.69523111 |
93 | Irritability (HP:0000737) | 1.69031847 |
94 | Myocardial infarction (HP:0001658) | 1.68931169 |
95 | Increased purine levels (HP:0004368) | 1.66675163 |
96 | Hyperuricemia (HP:0002149) | 1.66675163 |
97 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.66335423 |
98 | Polygenic inheritance (HP:0010982) | 1.65005326 |
99 | Abnormal hair laboratory examination (HP:0003328) | 1.63429132 |
100 | Periodontitis (HP:0000704) | 1.62614527 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MST1R | 6.24326500 |
2 | IRAK3 | 4.59502600 |
3 | EPHA2 | 4.51818291 |
4 | MET | 3.29702890 |
5 | ERN1 | 2.75628440 |
6 | MAP3K2 | 2.64441095 |
7 | ERBB4 | 2.53482137 |
8 | SIK1 | 2.45900898 |
9 | SMG1 | 2.44095599 |
10 | RIPK1 | 2.31564071 |
11 | TRIB3 | 2.27280388 |
12 | MAP3K3 | 2.26239652 |
13 | MAP3K12 | 2.11745771 |
14 | STK38 | 1.80918246 |
15 | FGFR4 | 1.79260906 |
16 | SCYL2 | 1.74206949 |
17 | PTK2 | 1.67107081 |
18 | RPS6KB2 | 1.67080620 |
19 | PAK4 | 1.66471471 |
20 | PBK | 1.66029151 |
21 | MAP3K9 | 1.63554547 |
22 | MAP2K6 | 1.63382913 |
23 | LATS1 | 1.55046357 |
24 | LATS2 | 1.44339363 |
25 | MAPKAPK3 | 1.40487649 |
26 | EIF2AK1 | 1.27919733 |
27 | ICK | 1.27134884 |
28 | TESK1 | 1.24957014 |
29 | PDGFRA | 1.23794076 |
30 | EPHB1 | 1.23762025 |
31 | ARAF | 1.22496818 |
32 | TBK1 | 1.11117303 |
33 | NTRK1 | 1.10418717 |
34 | PTK6 | 1.01539765 |
35 | NEK1 | 0.99899645 |
36 | PIK3CA | 0.96507862 |
37 | IRAK2 | 0.95168696 |
38 | MYLK | 0.91054324 |
39 | NME2 | 0.83548955 |
40 | CAMK2G | 0.81907402 |
41 | MAPK11 | 0.81811390 |
42 | CDK8 | 0.81214594 |
43 | FER | 0.78697844 |
44 | CDK9 | 0.78548282 |
45 | NEK9 | 0.76839670 |
46 | TTN | 0.76581700 |
47 | PDPK1 | 0.74688717 |
48 | PKN2 | 0.73329840 |
49 | IRAK1 | 0.72765031 |
50 | STK38L | 0.71409487 |
51 | PRKAA2 | 0.70852254 |
52 | MAP3K6 | 0.70776178 |
53 | MAP3K1 | 0.70482520 |
54 | PIK3CG | 0.69936089 |
55 | KSR2 | 0.68289052 |
56 | MAP3K13 | 0.64862676 |
57 | NEK6 | 0.64040202 |
58 | CDK12 | 0.63165543 |
59 | MAP2K2 | 0.61424163 |
60 | MTOR | 0.60516853 |
61 | BRSK2 | 0.59874870 |
62 | ABL2 | 0.58735632 |
63 | MAP2K1 | 0.58317846 |
64 | TYK2 | 0.55823908 |
65 | FGFR3 | 0.55727282 |
66 | CAMK2B | 0.55375680 |
67 | MST4 | 0.52870007 |
68 | PRKCI | 0.52785127 |
69 | TRPM7 | 0.52745328 |
70 | IGF1R | 0.52416354 |
71 | LRRK2 | 0.49227630 |
72 | PRKG2 | 0.47433203 |
73 | CDK6 | 0.46865452 |
74 | IRAK4 | 0.46432206 |
75 | EPHA3 | 0.45794219 |
76 | MAP3K8 | 0.44881054 |
77 | MAP2K4 | 0.44542780 |
78 | CSF1R | 0.43159412 |
79 | FLT3 | 0.41898097 |
80 | MELK | 0.38112544 |
81 | PRKACG | 0.37887442 |
82 | MAPK15 | 0.37825483 |
83 | MAP3K7 | 0.37655781 |
84 | PRKCZ | 0.34255922 |
85 | BCKDK | 0.33865279 |
86 | DAPK1 | 0.33701799 |
87 | ERBB2 | 0.33506730 |
88 | CDK7 | 0.30150894 |
89 | ZAP70 | 0.30084023 |
90 | CAMK2D | 0.28030478 |
91 | JAK1 | 0.27859016 |
92 | RET | 0.27055136 |
93 | BMX | 0.26463365 |
94 | MUSK | 0.26028029 |
95 | CDK4 | 0.25284944 |
96 | SRC | 0.24176953 |
97 | YES1 | 0.23857062 |
98 | LMTK2 | 0.22795807 |
99 | SGK3 | 0.22379719 |
100 | GSK3A | 0.22201001 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 4.44983824 |
2 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.79716346 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.46649641 |
4 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.46593227 |
5 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.35577574 |
6 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.34508278 |
7 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 3.26145097 |
8 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.23666060 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.21848121 |
10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.19780020 |
11 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.17646208 |
12 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 3.10308489 |
13 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.48838003 |
14 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.23987579 |
15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.21070686 |
16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.04707198 |
17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.04259733 |
18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.03698471 |
19 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.02544193 |
20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.98354849 |
21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.96573227 |
22 | Bile secretion_Homo sapiens_hsa04976 | 1.83810439 |
23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.83425676 |
24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.75147623 |
25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.74445436 |
26 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.43697033 |
27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.38566053 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.38558365 |
29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.35032993 |
30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.20035723 |
31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.19491332 |
32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18412545 |
33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16737371 |
34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.07465052 |
35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07267684 |
36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.06364546 |
37 | Peroxisome_Homo sapiens_hsa04146 | 1.05200414 |
38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99864628 |
39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99335061 |
40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.98722931 |
41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96004729 |
42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93520170 |
43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89876516 |
44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86041017 |
45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85357841 |
46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.84175475 |
47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82307358 |
48 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81019277 |
49 | ABC transporters_Homo sapiens_hsa02010 | 0.77692426 |
50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76589564 |
51 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75848962 |
52 | Prion diseases_Homo sapiens_hsa05020 | 0.74249667 |
53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72904828 |
54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72332869 |
55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70079496 |
56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.67947524 |
57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59692696 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59376914 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.53643477 |
60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47070951 |
61 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.41012502 |
62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38609140 |
63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38101481 |
64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.33235233 |
65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.28495749 |
66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27663707 |
67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.22431647 |
68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21800793 |
69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21474304 |
70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.17974621 |
71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.17717770 |
72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16028561 |
73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.15936921 |
74 | Pertussis_Homo sapiens_hsa05133 | 0.15928648 |
75 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.11711688 |
76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.10943107 |
77 | Insulin resistance_Homo sapiens_hsa04931 | 0.09696061 |
78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.09144873 |
79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08781092 |
80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.08308741 |
81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.06798442 |
82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.06445272 |
83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.04531863 |
84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.03430875 |
85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02468609 |
86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.00710377 |
87 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.00149533 |
88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1407453 |
89 | Hepatitis C_Homo sapiens_hsa05160 | -0.1288016 |
90 | Renal cell carcinoma_Homo sapiens_hsa05211 | -0.1269910 |
91 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1165000 |
92 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1156346 |
93 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1156050 |
94 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.1144300 |
95 | Bladder cancer_Homo sapiens_hsa05219 | -0.0740331 |
96 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0399731 |
97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0263984 |
98 | Amoebiasis_Homo sapiens_hsa05146 | -0.0238234 |
99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0213111 |
100 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0205885 |